| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT04059445 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P17 | country | Norway | Q20 |
| P582 | end time | 2027-06-15 | |
| P2899 | minimum age | 20 | |
| P1132 | number of participants | 41 | |
| P4844 | research intervention | calcium oxalate | Q412399 |
| P1813 | short name | FURC-II-REGEN | |
| P859 | sponsor | University of Oslo | Q486156 |
| P580 | start time | 2019-09-15 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Biphasic Calcium Phosphate and a Collagen Membrane or Biphasic Calcium Phosphate and Enamel Matrix Proteins, in the Regenerative Treatment of Furcation Grade II Defects |
Search more.